Unlock stock picks and a broker-level newsfeed that powers Wall Street.
9.89
-0.56
(-5.36%)
At close: April 4 at 4:00:02 PM EDT
10.02
+0.13
+(1.31%)
After hours: April 4 at 7:59:31 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 4 | 4 |
| Avg. Estimate | 0 | 0 | 0.37 | 0.4 |
| Low Estimate | 0 | 0 | 0.24 | 0.26 |
| High Estimate | 0 | 0 | 0.5 | 0.54 |
| Year Ago EPS | -- | -- | 0.45 | 0.37 |
Revenue Estimate
| Currency in GBP | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 2 | 16 | 15 |
| Avg. Estimate | 2.87B | 2.77B | 11.46B | 12B |
| Low Estimate | 2.85B | 2.75B | 11.36B | 11.84B |
| High Estimate | 2.88B | 2.79B | 11.6B | 12.2B |
| Year Ago Sales | 2.92B | 2.77B | 11.23B | 11.46B |
| Sales Growth (year/est) | -1.67% | -0.13% | 2.06% | 4.68% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 |
|---|---|---|
| EPS Est. | 0.09 | 0.11 |
| EPS Actual | 0.1 | 0.12 |
| Difference | 0.01 | 0.01 |
| Surprise % | 13.74% | 11.50% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0.37 | 0.4 |
| 7 Days Ago | 0 | 0 | 0.37 | 0.4 |
| 30 Days Ago | 0 | 0 | 0.36 | 0.4 |
| 60 Days Ago | 0 | 0 | 0.4 | 0.39 |
| 90 Days Ago | 0 | 0 | 0.37 | 0.36 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 2 | 2 |
| Up Last 30 Days | -- | -- | 2 | 2 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| HLN | -- | -- | -19.65% | 9.19% |
| S&P 500 | 6.57% | 6.54% | 9.73% | 14.28% |
Upgrades & Downgrades
| Maintains | Morgan Stanley: Overweight to Overweight | 9/20/2024 |
| Maintains | Argus Research: Buy to Buy | 3/26/2024 |
| Initiated | Morgan Stanley: Overweight | 11/1/2023 |
| Upgrade | Argus Research: Hold to Buy | 4/6/2023 |
| Initiated | Argus Research: Hold | 9/28/2022 |
| Initiated | Deutsche Bank: Hold | 7/29/2022 |
Related Tickers
VTRS Viatris Inc.
7.62
-6.62%
TAK Takeda Pharmaceutical Company Limited
14.72
-3.09%
ELAN Elanco Animal Health Incorporated
9.15
-5.86%
PRGO Perrigo Company plc
26.31
-2.19%
ITCI Intra-Cellular Therapies, Inc.
131.87
0.00%
BHC Bausch Health Companies Inc.
5.33
-6.00%
ALVO Alvotech
8.50
-8.31%
TEVA Teva Pharmaceutical Industries Limited
13.80
-7.07%
HCM HUTCHMED (China) Limited
14.38
-5.70%
PBH Prestige Consumer Healthcare Inc.
82.85
-2.01%